Autoantibodies in long COVID: A mechanistic foothold in a heterogeneous disease

Authors list

Emma Wall Alex G Richter
Scroll for detail on labs, facilities & authors

Abstract

Long COVID is a heterogeneous, multi-system disease that poses challenges for patients, health systems, and economies. Two papers in Cell and Cell Reports Medicine from independent groups suggest that autoantibodies in a subset of long COVID patients can directly drive symptoms such as pain, fatigue, or neurocognitive problems.

Journal details

Journal Cell
Volume 189
Issue number 11
Pages 3179-3180
Available online
Publication date

Full text links

Publisher website (DOI) 10.1016/j.cell.2026.04.044
Europe PubMed Central 42208496
Pubmed 42208496

Keywords

Related topics
Type of publication

Crick labs/facilities

Crick authors

Crick First author
Crick Corresponding author